|Articles|September 16, 2009
- Fall 2009
- Volume 8
- Issue 3
CYP2D6 Inhibitors
Advertisement
>
Strong CYP2D6 Inhibitors* Paxil (paroxetine)
>
Prozac (fluoxetine)
>
Wellbutrin (bupropion)
>
Moderate CYP2D6 Inhibitors Cymbalta (duloxetine)
>
Zoloft (sertraline)
>
Weak CYP2D6 Inhibitors Celexa (citalopram)
>
Effexor (venlafaxine)
>
Lexapro (escitalopram)
Source: Abbreviated listing from Handbook of Essential Psychopharmacology, second edition, 2005
*To be avoided with tamoxifen
Articles in this issue
about 16 years ago
Web Exclusive: Quiz: Do You Know the Recommended Screening Guidelines?about 16 years ago
Web Exclusive: When is Multidisciplinary Care Really Needed?about 16 years ago
The Internal Flameabout 16 years ago
Message from the Editorabout 16 years ago
Letters from Our Readersabout 16 years ago
Overheatedabout 16 years ago
I Laughedabout 16 years ago
Kidney Cancer & Lung Cancerabout 16 years ago
Cancer Screeningabout 16 years ago
Life Preserver?Advertisement
Advertisement
Advertisement
Trending on CURE
1
Single-Drug Approach Explored for Newly Diagnosed Multiple Myeloma
2
FDA Approves Akeega Combo in BRCA2+ Metastatic Prostate Cancer
3
What Does Minimal Residual Disease Mean?
4
Radiation Plus Keytruda Before Surgery Boosts Immune Response in Breast Cancer
5
